B Jégou1, J F Velez de la Calle
1Groupe d'étude de la reproduction chez la mâle (GERM), INSERM CJF 91-04, Université de Rennes I, Bretagne, France.
Protecting male fertility from cytotoxic cancer therapies is crucial. The combination of medroxyprogesterone acetate and testosterone (MPA+T) shows promise in protecting sperm quality and quantity against chemotherapy and radiotherapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: